US Senator raises alarm over poor-quality drug imports from India and China, seeks tougher FDA inspections

In a letter to FDA Commissioner Martin Makary, Banks said the agency must "do more to protect the US drug supply," warning that lax oversight could endanger American consumers. He pointed out that inspections of foreign drug plants have not yet returned to pre-pandemic levels, even as the number of manufacturers continues to grow.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xEIYczF
via IFTTT